DataJoint, a data management platform based in Austin, Texas, specializing in AI-driven solutions for life sciences and pharmaceutical research, has successfully raised $4.9 million in seed funding. The investment round was co-led by Nina Capital, Inoca Capital Partners, and Capital Factory, with additional backing from existing investors.
Nina Capital, a Barcelona-based venture capital firm, focuses on innovations at the intersection of healthcare and technology. Since its inception in 2019, it has invested in 52 companies across 18 countries. Inoca Capital Partners, located in Salt Lake City, is a private equity firm that collaborates with management teams to foster growth in sectors like Data + AI, Cloud, and Healthcare/IT. Capital Factory, a hybrid accelerator and venture capital firm, serves as a hub for technological innovation in Texas, linking startups with investors and talent.
With the new funds, DataJoint aims to scale its operations, enhance its SaaS platform, and broaden its market presence in the U.S. and Europe. The company offers a unified database infrastructure that streamlines multimodal data sources into automated workflows, facilitating research in neuroscience, oncology, and systems biology. Currently, DataJoint supports over 100 labs, including prestigious institutions like Johns Hopkins, UCSF, Harvard, and UCL. The platform is built on an open-source foundation and is working towards achieving SOC2, HIPAA, and ISO27001 compliance to better serve its expanding customer base.
